News

Iodixanol Iopamidol Contrast Media Peripheral Arteriography ACC.14 Clinical Stud

GE Healthcare announced results from a new clinical study, which showed that patients receiving iodixanol (Visipaque) 320mg I/ml reported less discomfort, characterized by heat or cold sensation...

Manhattan Scientifics announced a collaboration with Azano Biotech that will make NanoMRX Precision Nanoparticles available for purchase.

Guerbet FlowSens Contrast Media Injectors CT Systems X-Ray

Guerbet announced a worldwide launch of FlowSens, a contrast agent injection solution used in...

mri systems contrast media diamonds nanodiamonds cambridge

Researchers say they have achieved enough coherence of the magnetic moment inherent in the defects of miniscule diamond fragments to harness their potential for precise quantum sensors in a...

GE Healthcare announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture Optison (Perflutren Protein-Type A Microspheres Injectable Suspension,...

No law prevents doctors from freely prescribing U.S. Food and Drug Administration (FDA)-approved drugs and devices for off-label uses, yet regulators continue to aggressively pursue civil and...

contrast medica injectors ct systems rsna 2013 bracco syringe packs empowercta

Bracco Diagnostics Inc. announced the availability of syringe packs with spikes, to be used when...

September 5, 2013 — Scientists at Rice University have trapped bismuth in a nanotube cage to tag stem cells for X-ray tracking. Details of the work by a team from Rice and collaborators at the...

Positron Corp PosiRx 3000-Series Pharmacy Automation Systems

Positron Corp. announced the release of the PosiRx 3000-Series, its latest pharmacy automation systems. The PosiRx 3000-Series are the first systems to automate and encompass the complete...

A new method of dynamic, personalized intravenous hydration significantly reduces the percentage of contrast-induced kidney injury from image-guided cardiovascular procedures, according to the...

Guerbet announced that the U.S. Food and Drug Administration (FDA) has approved Dotarem (gadoterate meglumine), a gadolinium-based contrast agent (GBCA) indicated for intravenous use with magnetic...

March 14, 2013 — Lantheus Medical Imaging Inc. announced the U.S. Food and Drug Administration (FDA) has granted approval of a supplemental new drug application (sNDA) that allows Jubilant...

Contrast Agents Mayo Clinic Clinical Study Kidney Injury

Many physicians have long believed that the use of intravenous contrast agents for computed tomography (CT) scans can cause acute kidney injury. New Mayo Clinic research questions the strength of...

Bayer Healthcare is expanding its global distribution network for the Medrad Intego positron emission tomography (PET) Infusion System through a new distribution agreement with Comecer SPA....

Dotarem Guebert LLC FDA NDA Approval Contrast Media MRI Systems

Guerbet announced that the Medical Imaging Drugs Advisory Committee to U.S. Food and Drug Administration (FDA) has voted unanimously by votes of 17 to zero to recommend that FDA approve the New...

Performing heart surgery on the same day as angiography is now confirmed as a risk factor for acute kidney injury (AKI), and hospital policy limiting the practice for elective cardiac surgery has...

GE Healthcare announced that it has filed a supplemental new drug application (sNDA) that will allow the company to manufacture Optison (Perflutren Protein-Type A Microspheres Injectable...

Bracco Diagnostics Inc. is voluntarily initiating a Class I recall of nine lots of Isovue (iopamidol injection) pre-filled power injector syringes (Isovue PFS, to be used in combination with...

Clinical Study Catherization Kindey Damage Contrast Media

November 8, 2012 — A hydration regimen tailored to the patient’s fluid status was effective in reducing damage to kidneys in patients undergoing cardiac catheterization, according to a study...

New research from the Netherlands suggests tiny microbubbles can be used to more effectively deliver a blood clot busting drug to patients while they are in the ambulance during acute heart attack...

August 28, 2012 — The International Contrast Ultrasound Society (ICUS) applauded the U.S. Food and Drug Administration’s (FDA) decision to modify the U.S. product label for several ultrasound...

August 28, 2012 — GE Healthcare announced important changes to the U.S. product label for Optison (perflutren protein-type A microspheres injectable suspension, USP), a...

July 31, 2012 — Bracco Diagnostics Inc., the U.S.-based company of the Bracco Group, announced that the U.S. Food and Drug Administration (FDA) has approved the use of MultiHance (gadobenate...

July 20, 2012 —Acusphere Inc. announced that it had completed the marketing authorization application (MAA) dossier for its lead product candidate, Imagify (perflubutane polymer microspheres) for...

July 13, 2012 — GE Healthcare and VPDiagnostics Inc. jointly announced today their co-marketing agreement for the VPDiagnostics’ MRI-PlaqueView software for carotid artery...

July 11, 2012 — Lantheus Medical Imaging Inc., a developer, manufacturer and distributor of diagnostic imaging agents, announced the publication of results from the CaRES (Contrast...

June 22, 2012 — Bayer HealthCare’s Radiology and Interventional unit has launched the new Mark 7 Arterion Injection System, the latest in the Medrad Mark series of angiographic...

June 8, 2012 — Bayer HealthCare announced the formation of a strategic partnership with Radimetrics Inc. that will offer U.S. healthcare professionals the industry’s first computed tomography...

June 8, 2012 — Bayer Radiology and Interventional has announced the introduction of the Certegra Workstation, an informatics-driven, touch-screen hub that enables time savings and improved patient...

Several technological advancements occurred in the PICC market in recent years that are changing the competitive landscape and driving growth. Increasingly, medical professionals are using...

May 14, 2012 — Lantheus Medical Imaging Inc. announced new manufacturing and supply agreements with Jubilant HollisterStier LLC (JHS). Under separate agreements, JHS will manufacture Cardiolite...

April 13, 2012 — Researchers at The Ohio State University (OSU) Wexner Medical Center have successfully used nanotechnology to target a protein that plays a key role in atherosclerosis...

April 4, 2012 — Medrad (Bayer) recently introduced the Mark 7 Arterion angiographic contrast injection system. The system is much smaller, lighter-weight, more ergonomic and easier to maneuver...

Incidences of renal complications, specifically acute renal failure (ARF) and new hemodialysis (HD), continue to increase significantly among Medicare beneficiaries (MB) admitted for percutaneous...

March 12, 2012 — A new study shows that the use of gadobenate dimeglumine, the highest relaxivity gadolinium-based contrast agent (GBCA) available for central nervous system (CNS) magnetic...

March 9, 2012 — Researchers have developed a method to label transplanted cells so they can be tracked by magnetic resonance imaging (MRI). In the future, as cell therapies become a more integral...

March 7, 2012 — Covidien announced the global launch of the Optivantage dual-head computed tomography (CT) contrast media delivery system with simultaneous injection.

February 29, 2012 — Lantheus Medical Imaging Inc. announced a strategic distribution arrangement for its Definity cardiac ultrasound contrast agent in the People’s Republic of China, including...

February 2, 2012 — AngioDynamics entered into a definitive agreement to acquire privately held Navilyst Medical in a transaction valued at $372 million based on the Jan. 30 closing stock price of...

January 18, 2012 — PLC Systems Inc. announced that final results from the MYTHOS investigator-sponsored clinical trial of RenalGuard in Italy have been published in the January 2012 issue of ...

January 6, 2012 - Bracco Imaging SpA has acquired Swiss Medical Care (SMC), a Swiss company headquartered in Lausanne and engaged in research, production and marketing of automated systems for the...

December 29, 2011 — Medrad Inc. recently released the Certegra Informatics Connect.RIS vendor-neutral informatics application. The system establishes connectivity between Medrad's Stellant...

November 14, 2011 – The American Society of Echocardiography (ASE) reported that the Cardiovascular and Renal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee of...

November 3, 2011 – Lantheus Medical Imaging announced important changes to the U.S. product label for Definity Vial for (perflutren lipid microsphere) Injectable Suspension. The contrast agent is...

October 26, 2011 –Lantheus Medical Imaging announced it has been awarded three-year supplier contracts with Premier Purchasing Partners, the group purchasing unit of the Premier healthcare...

October 4, 2011 – The International Contrast Ultrasound Society (ICUS) submitted a petition this week to the U.S. Food and Drug Administration (FDA) requesting removal of the boxed warnings on...

August 23, 2011 — PLC Systems Inc. said the final results from the REMEDIAL II investigator-sponsored clinical trial have been published online in Circulation, a peer-reviewed journal of...

August 9, 2011 — Acist Medical Systems Inc., a Bracco Group company and provider of advanced contrast injection system technology for cardiovascular angiography, announced that its’ Contrast...

July 29, 2011 — Oxygen Biotherapeutics Inc. and privately held Aurum Biosciences Ltd. of Glasgow, Scotland, have signed a letter of intent (LOI) to conduct preclinical research for imaging and...

June 13, 2011 – Today, GE Healthcare Medical Diagnostics announced results of a study evaluating the cardiopulmonary safety of Optison (Perflutren Protein-Type A Microspheres Injectable Suspension,...
May 20, 2011 -- Medrad Inc., a business of Bayer HealthCare, has announced the launch of the next generation Intego PET Infusion System, which features a new design that is 38 percent smaller, power-...
May 10, 2011 – A simple blood test may help prevent a serious complication associated with a contrast agent commonly used in MRI exams, according to a study published in the July issue of ...

February 14, 2011 – A new bedside insertion kit and power-injectable catheter has been launched. The Morpheus Smart PICC insertion kit and 5 French Dual Lumen Peripherally Inserted Central...

January 24, 2011 – Lantheus Medical Imaging has entered into a contract with Novation for Ablavar (gadofosveset trisodium) and Definity Vial for Injectable Suspension (Perflutren Lipid...

Contrast-enhanced ultrasound (CEUS) can "dramatically improve" physicians' ability to detect heart disease and stratify future risk, said Thomas Porter, M.D., at the 16th European Symposium on...

December 17, 2010 – An ultrasound contrast agent is under review by the U.S. Food and Drug Administration (FDA) for use in stress echocardiography. Lantheus Medical Imaging recently submitted a...

December 16, 2010 – Bracco Imaging demonstrated how its customized evidence-based diagnostic imaging solutions are meeting the demands of an evolving radiology market at the Radiological Society...

October 14, 2010 – An injectable magnetic resonance angiography (MRA) blood pool imaging agent has been released in Canada. Ablavar, which is made by Lantheus Medical Imaging and previously...

September 10, 2010 – The U.S. Food and Drug Administration (FDA) is requiring that gadolinium-based contrast agents (GBCAs) carry new warnings on their labels about the risk of a rare and...

August 25, 2010 - Polymer bottle packaging for contrast media is now included in the GE Healthcare ecomagination campaign. The +Pluspak, a packaging container for contrast media, offers...

August 25, 2010 – Evidence suggests the use of contrast agents for echocardiography is safe and not associated with a greater incidence of myocardial infarction or mortality, according to a new...

August 18, 2010 - Researchers from Mount Sinai School of Medicine have for the first time developed a way to visualize coronary artery plaques vulnerable to rupture using multicolor computed...

July 16, 2010 – Lantheus Medical Imaging Inc. this week announced the launch of its ultrasound contrast imaging agent, Definity Vial For (Perflutren Lipid Microsphere) Injectable Suspension, in...

July 12, 2010 – GE Healthcare Medical Diagnostics today announced the market reintroduction of Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound...

July 12, 2010 – Lantheus Medical Imaging Inc. today announced that it has acquired the balance of the worldwide rights for gadofosveset trisodium, a unique, injectable magnetic resonance...

July 9, 2010 – Lantheus Medical Imaging Inc. announced this week that it has signed a new manufacturing and supply agreement with MDS Nordion to purchase molybdenum-99 (Mo-99), the parent isotope...

June 15, 2010 – A new study evaluating the safety of an echocardiography contrast agent found that the agent did not have a significant effect on patients’ pulmonary pressures.

June 8, 2010 – A recent study found a potential new molecular imaging agent combined with post-scan image processing technology could result in crisper pictures of the heart. The results were...

June 4, 2010 – The first national contract signed for a magnetic resonance imaging angiography (MRA) contrast agent was been signed, making it available to more than 27,000 medical facilities.

June 3, 2010 – A joint research agreement will explore the targeted delivery of experimental therapeutics based on ribonucleic acid (RNA) interference (RNAi). Philips Healthcare and RXi...

May 24, 2010 - Utilizing the iso-osmolar agent Visipaque (iodixanol) could save hospitals $54,617 per 100 patients when compared to the low osmolar nonionic agent iopamidol. This was according to...

May 20, 2010 – A new partnership enables data communication between Medrad's Intego positron emission tomography (PET) infusion system and Pinestar Technology's Nuclear Medicine Information System...

May 19, 2010 – Three distinct lumens in a new line of peripherally inserted central catheters (PICCs) increase flexibility to administer medications simultaneously. It also allows contrast power...

May 19, 2010 – A new study shows a single photon emission computed tomography (SPECT) imaging agent can identified symptomatic heart failure patients most likely to experience cardiac events.

February 17, 2010 — An agreement has been reached to further augment and diversify a manufacturer's supply of molybdenum 99 (Mo 99) to produce the medical isotope technetium 99m (Tc 99m).